Showing posts with label parathyroid hormone. Show all posts
Showing posts with label parathyroid hormone. Show all posts

September 17, 2013

Post-surgical follow-up of primary hyperparathyroidism associated with MEN1

Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1

-Flavia L. Coutinho, Delmar M. Lourenco, Jr.,I Rodrigo A. Toledo, Fabio L. M. Montenegro, and Sergio P. A. Toledo
Clinics (Sao Paulo). 2012 April; 67(Suppl 1): 169–172.
doi: 10.6061/clinics/2012(Sup01)28. PMCID: PMC3328812


  • In patients with hyperparathyroidism and MEN1, parathyroidectomy in most cases "was able to restore normal calcium/parathyroid hormone levels and ultimately lead to discontinuation of calcium and calcitriol supplementation."

August 20, 2013

Diagnosis of MEN1 in a patient with back pain

Diagnosis Of Multiple Endocrine Neoplasia Type 1 In A Patient With Back Pain; Case Report And Review Of Literature
-G Cristina, L Cesar A, L Robert, M Vinuta. Diagnosis Of Multiple Endocrine Neoplasia Type 1 In A Patient With Back Pain; Case Report And Review Of Literature. The Internet Journal of Internal Medicine. 2008 Volume 8 Number 1.

  • "Usually MEN1 patients are first diagnosed when they present with hypercalcemia. Our patient’s diagnosis was made only after he presented with back and flank pain, and imaging of his abdomen incidentally noted multiple abdominal tumors."

May 30, 2012

Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations

Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations
-Haglund F, et al. PLoS ONE May 2012, Volume 7, Issue 5, e36448.
  • "...the prolactin receptor is highly abundant in human parathyroid tissues"
  • "...PRLr isoforms expression and PRLr subcellular localisation are altered in parathyroid tumours."
  • "Responsiveness of PRLr to physiological levels of prolactin was observed in the form of increased PTH secretion and altered gene transcription with significant increase of RIG-I like receptor, JAK-STAT and Type II interferon signalling pathways."
  • "These data suggest a role of the prolactin receptor in parathyroid adenomas."